Stayble is a clinical stage pharmaceutical company developing the injection treatment STA363 for disc-related chronic low back pain. The treatment is aimed at patients whose back pain persists after physiotherapy and painkillers. The injection is given once and the effect is expected to remain throughout the entirety of the patient’s life and requires minimal rehabilitation. The Company’s focus is set upon the continued clinical development of the upcoming phase 2b study. Stayble’s vision is to develop STA363 as a new standard treatment for patients suffering from chronic disc-related low back pain.
Location: Sweden, Gothenburg
Employees: 1-10
Founded date: 2015
Investors 2
| Date | Name | Website |
| - | Almi Inves... | almi.se |
| - | Chalmers V... | chalmersve... |
Mentions in press and media 10
| Date | Title | Description | Source |
| 17.04.2024 | (SV) Stayble Therapeutics publicerar årsredovisningen för 20... | (SV) Stayble Therapeutics publicerar årsredovisningen för 2023 Wed, Apr 17, 2024 14:38 CET Report th... | news.cisio... |
| 15.04.2024 | (SV) Kallelse till årsstämma i Stayble Therapeutics AB | (SV) Kallelse till årsstämma i Stayble Therapeutics AB Mon, Apr 15, 2024 09:30 CET Report this conte... | news.cisio... |
| 09.05.2023 | (SE) Stayble Therapeutics publicerar årsredovisningen för 20... | (SE) Stayble Therapeutics publicerar årsredovisningen för 2022 Tue, May 09, 2023 16:01 CET Report th... | news.cisio... |
| 02.05.2023 | (SE) Kallelse till årsstämma i Stayble Therapeutics AB | (SE) Kallelse till årsstämma i Stayble Therapeutics AB Tue, May 02, 2023 16:43 CET Report this conte... | news.cisio... |
| 17.03.2023 | Stayble Therapeutics AB publishes prospectus relating to the... | Stayble Therapeutics AB publishes prospectus relating to the rights issue Fri, Mar 17, 2023 13:40 CE... | news.cisio... |
| 22.02.2023 | (SE) - Kallelse till extra bolagsstämma i Stayble Therapeuti... | (SE) - Kallelse till extra bolagsstämma i Stayble Therapeutics AB Wed, Feb 22, 2023 21:20 CET Report... | news.cisio... |
| 22.02.2023 | Stayble Therapeutics AB starts development of a new clinical... | Stayble Therapeutics AB starts development of a new clinical indication and decides on a rights issu... | news.cisio... |
| 21.02.2023 | Stayble Therapeutics publishes year-end report for 2022 | Stayble Therapeutics publishes year-end report for 2022 Tue, Feb 21, 2023 08:00 CET Report this cont... | news.cisio... |
| 30.11.2022 | Stayble Therapeutics presents at ProHearings Capital Market ... | Stayble Therapeutics presents at ProHearings Capital Market Day on December 1 2022 Wed, Nov 30, 2022... | news.cisio... |
| 22.02.2022 | Stayble Therapeutics: Publication of year-end report 2021 | Stayble Therapeutics: Publication of year-end report 2021 Tue, Feb 22, 2022 08:00 CET Report this co... | news.cisio... |